Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2007 2
2009 6
2010 3
2011 4
2012 3
2013 6
2014 2
2015 2
2016 1
2017 5
2018 6
2019 10
2020 10
2021 13
2022 10
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. Mejzini R, et al. Among authors: fletcher s. Front Neurosci. 2019 Dec 6;13:1310. doi: 10.3389/fnins.2019.01310. eCollection 2019. Front Neurosci. 2019. PMID: 31866818 Free PMC article. Review.
YAPping about and not forgetting TAZ.
Callus BA, Finch-Edmondson ML, Fletcher S, Wilton SD. Callus BA, et al. Among authors: fletcher s. FEBS Lett. 2019 Feb;593(3):253-276. doi: 10.1002/1873-3468.13318. Epub 2019 Jan 15. FEBS Lett. 2019. PMID: 30570758 Free article. Review.
Stargardt disease and progress in therapeutic strategies.
Huang D, Heath Jeffery RC, Aung-Htut MT, McLenachan S, Fletcher S, Wilton SD, Chen FK. Huang D, et al. Among authors: fletcher s. Ophthalmic Genet. 2022 Feb;43(1):1-26. doi: 10.1080/13816810.2021.1966053. Epub 2021 Aug 29. Ophthalmic Genet. 2022. PMID: 34455905 Review.
DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics.
Larcher LM, Pitout IL, Keegan NP, Veedu RN, Fletcher S. Larcher LM, et al. Among authors: fletcher s. Nucleic Acid Ther. 2023 Jun;33(3):178-192. doi: 10.1089/nat.2022.0066. Epub 2023 Apr 21. Nucleic Acid Ther. 2023. PMID: 37093127 Free PMC article. Review.
Pathogenesis and Treatment of Usher Syndrome Type IIA.
Zaw K, Carvalho LS, Aung-Htut MT, Fletcher S, Wilton SD, Chen FK, McLenachan S. Zaw K, et al. Among authors: fletcher s. Asia Pac J Ophthalmol (Phila). 2022 Jul-Aug 01;11(4):369-379. doi: 10.1097/APO.0000000000000546. Epub 2022 Aug 17. Asia Pac J Ophthalmol (Phila). 2022. PMID: 36041150 Free article. Review.
Determinants of Disease Penetrance in PRPF31-Associated Retinopathy.
McLenachan S, Zhang D, Grainok J, Zhang X, Huang Z, Chen SC, Zaw K, Lima A, Jennings L, Roshandel D, Moon SY, Heath Jeffery RC, Attia MS, Thompson JA, Lamey TM, McLaren TL, De Roach J, Fletcher S, Chen FK. McLenachan S, et al. Among authors: fletcher s. Genes (Basel). 2021 Sep 28;12(10):1542. doi: 10.3390/genes12101542. Genes (Basel). 2021. PMID: 34680937 Free PMC article.
Response to "Railroading at the FDA".
Muntoni F, Fletcher S, Wilton S. Muntoni F, et al. Among authors: fletcher s. Nat Biotechnol. 2017 Mar 7;35(3):207-209. doi: 10.1038/nbt.3819. Nat Biotechnol. 2017. PMID: 28267731 No abstract available.
80 results